Spire Wealth Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Spire Wealth Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,000	Closed	-$7K	–	2879
2022 Q1	$7K	Hold	4,000	–	–	﹤0.01%	2174
2021 Q4	$9K	Hold	4,000	–	–	﹤0.01%	2430
2021 Q3	$13K	Hold	4,000	–	–	﹤0.01%	2025
2021 Q2	$11K	Hold	4,000	–	–	﹤0.01%	2097
2021 Q1	$9K	Buy	+4,000	New	+$11.4K	﹤0.01%	2463

Other funds holding ETTX

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Spire Wealth Management's ETTX Position: Q2 2022 in Review

Spire Wealth Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2022, closing a stake of 4,000 shares — an estimated $7K sold.

Spire Wealth Management first reported a position in ETTX in Q1 2021 and held it in 5 quarters. The position peaked at $13K in Q3 2021. 27 funds tracked by Wall St. Rank hold ETTX as of Q2 2022.

Spire Wealth Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2022 after selling out during the quarter.
Spire Wealth Management sold 4,000 Entasis Therapeutics Holdings Inc. shares in Q2 2022, an estimated $7K.
Spire Wealth Management first reported a position in Entasis Therapeutics Holdings Inc. in Q1 2021 and held it in 5 quarters.
Spire Wealth Management's Entasis Therapeutics Holdings Inc. position peaked at $13K in Q3 2021.
27 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2022.

Based on Spire Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.